- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
Patent holdings for IPC class C12N 15/113
Total number of patents in this class: 29571
10-year publication summary
|
1561
|
1732
|
1998
|
1969
|
2285
|
2375
|
2573
|
2789
|
2819
|
325
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Alnylam Pharmaceuticals, Inc. | 1153 |
743 |
| Ionis Pharmaceuticals, Inc. | 916 |
609 |
| The Regents of the University of California | 20366 |
588 |
| University of Massachusetts | 2271 |
415 |
| Massachusetts Institute of Technology | 10178 |
282 |
| President and Fellows of Harvard College | 6053 |
247 |
| Arrowhead Pharmaceuticals, Inc. | 333 |
221 |
| Regeneron Pharmaceuticals, Inc. | 4510 |
221 |
| The Broad Institute, Inc. | 1903 |
214 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3354 |
206 |
| The General Hospital Corporation | 4794 |
200 |
| The Board of Trustees of the Leland Stanford Junior University | 6590 |
178 |
| Centre National de La Recherche Scientifique | 10802 |
175 |
| Hoffmann-La Roche Inc. | 3603 |
160 |
| Sarepta Therapeutics, Inc. | 385 |
153 |
| Monsanto Technology LLC | 8259 |
151 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3084 |
141 |
| Board of Regents, The University of Texas System | 6004 |
138 |
| The Trustees of the University of Pennsylvania | 4382 |
134 |
| Duke University | 3157 |
132 |
| Other owners | 24263 |